{
    "title": "Bristol-Myers confident of approvals linked to higher Celgene investor payout -Bristol exec",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7870191/Bristol-Myers-confident-approvals-linked-higher-Celgene-investor-payout-Bristol-exec.html",
    "date": "2020-01-09",
    "keywords": [
        "hirawat",
        "company",
        "cvr",
        "drug",
        "combination",
        "deal",
        "approval",
        "immunotherapy",
        "erman",
        "carl",
        "officer",
        "celgene",
        "march",
        "track",
        "fda",
        "end",
        "lymphoma",
        "treatment",
        "therapy",
        "idecel",
        "development",
        "inhibitor",
        "cancer",
        "year",
        "quarter",
        "york",
        "jan",
        "co",
        "payout",
        "acquisition",
        "part",
        "agreement",
        "contingent",
        "value",
        "share",
        "highprofile",
        "pipeline",
        "samit",
        "interview",
        "goal",
        "wednesday",
        "unit",
        "implying",
        "chance",
        "food",
        "administration",
        "ozanimod",
        "decision",
        "december",
        "lisocel",
        "trial",
        "application",
        "agency",
        "asset",
        "myeloma",
        "bb2121",
        "filing",
        "novartis",
        "drugmaker",
        "portfolio",
        "door",
        "multidrug",
        "example",
        "blockbuster",
        "opdivo",
        "type",
        "strategy",
        "companys",
        "growth",
        "driver",
        "hovering",
        "dominance",
        "merck",
        "amp",
        "cos",
        "keytruda",
        "lung",
        "oncology",
        "market",
        "cash",
        "cow",
        "revlimid",
        "addition",
        "relatlimab",
        "class",
        "lag3",
        "potential",
        "io",
        "immunooncology",
        "armamentarium",
        "melanoma",
        "exist",
        "thursday",
        "reporting",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}